a research and InNOvation Partnership for enhancing the surveillance and control of mosquito VECtors of emerging arboviruses

在过去10年中，登革热、寨卡病毒、基孔肯雅热和黄热病等虫媒病毒性疾病（重新）出现，其流行程度和严重程度日益增加。尽管这些虫媒病毒性疾病在热带国家更为流行，但欧洲国家报告的本土病例数量也在不断增加；因此，人们对这些病原体在温带地区存在的可能性感到担忧。在缺乏有效疫苗和治疗方法的情况下，在全球范围内预防这些疾病仍然主要取决于控制蚊子病媒种群，中断人与病媒的接触，或两者兼而有之。不幸的是，最近伊蚊传播的虫媒病毒性疾病在世界范围内死灰复燃，突显了目前控制病媒在预防流行病和减少疾病发病率方面的局限性。迫切需要新的、负担得起的、可扩展的和基于社区的病媒控制措施，以防止伊蚊传播疾病在欧洲和其他地区的传入、传播和确立。INOVEC项目提议建立一个大型的泛欧洲、跨部门和多学科网络，以开发、优化和促进监测和控制新出现虫媒病毒的蚊子媒介的综合方法和创新工具。INOVEC将聚集21个专门从事病媒生物学、社会科学和产品开发的学术和非学术机构，以刺激基础研究和应用研究，加强能力，促进职业发展，并促进向患虫媒病毒病风险日益增加的国家转让知识和技术。INOVEC致力于协调和整合行业，以最大限度地发挥影响力，提高政策制定者和利益相关者的意识，并参与提高欧洲和全球层面的创新潜力。INOVEC将通过减少病媒传播疾病的负担，为改善全球健康和人类福祉的国际努力作出贡献。

Over the past 10 years, arboviral diseases, such as dengue, Zika, chikungunya and yellow fever, have (re)emerged with increasing prevalence and severity. Although these arboviral diseases are more prevalent in tropical countries, increasing numbers of autochthonous cases are being reported from European countries; hence raising concerns about the potential for the establishment of these pathogens in temperate regions. In the absence of effective vaccines and treatments, preventing these diseases at the global scale continues to depend largely on controlling mosquito vector populations, interrupting human-vector contact or both. Unfortunately, the recent resurgence of Aedes transmitted arboviral diseases worldwide highlights the limitations of current vector control to prevent epidemics and to reduce the incidence of diseases. New, affordable, scalable and community-based vector control measures are urgently needed to prevent the introduction, spread and establishment of Aedes-borne diseases in Europe and beyond. The INOVEC project proposes to build a large pan-European, cross-sectoral and multidisciplinary network to develop, optimise and promote integrated approaches and innovative tools for the surveillance and control of mosquito vectors of emerging arboviruses. INOVEC will gather 21 academic and non-academic institutions specialized in vector biology, social sciences and product development to stimulate basic and applied research, strengthen capacities, promote career development and facilitate knowledge and technology transfer to countries at increasing risk of arboviral diseases. INOVEC has the commitment to coordinate and integrate sectors in order to maximise impact, raise awareness of policy makers and stakeholders, and participate in the improvement of innovation potential at the European and global level. INOVEC will contribute to international efforts to improve global health and human well-being by reducing the burden of vector borne diseases.